GUSELKUMAB

GUSELKUMAB was reported 12324 times

GUSELKUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CROSS INFECTION 2 0.1667
1 GALLBLADDER ADENOCARCINOMA 6 0.1154
2 DRUG DELIVERY SYSTEM MALFUNCTION 322 0.1005
3 ENTHESOPHYTE 2 0.0952
4 IMPETIGO HERPETIFORMIS 2 0.0833
5 PRODUCT LEAKAGE 163 0.0622
6 NEOPLASM OF ORBIT 2 0.0606
7 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 10 0.0461
8 NONALCOHOLIC FATTY LIVER DISEASE 7 0.0348
9 NEEDLE ISSUE 521 0.0322
10 MANUFACTURING PRODUCT STORAGE ISSUE 2 0.0312
11 ESCHERICHIA PYELONEPHRITIS 5 0.0311
12 EYELID RETRACTION 2 0.0303
13 CONTRAINDICATION TO VACCINATION 5 0.0287
14 BLOOD URIC ACID DECREASED 10 0.0272
15 PRODUCT DOSE OMISSION ISSUE 2886 0.0263
16 ACNE FULMINANS 3 0.0234
17 ACCIDENTAL EXPOSURE TO PRODUCT 1155 0.0228
18 INJECTION SITE PLAQUE 3 0.0205
19 CHILLBLAINS 4 0.0202
20 PATERNAL EXPOSURE DURING PREGNANCY 8 0.0198
21 IMMUNISATION 2 0.0196
22 APPLICATION SITE WOUND 2 0.0192
23 SAPHO SYNDROME 3 0.0186
24 NON-ALCOHOLIC FATTY LIVER 3 0.0183
25 HYPERTROPHY 8 0.0177
26 SYRINGE ISSUE 175 0.0177
27 PRODUCT DESIGN ISSUE 5 0.0174
28 LIQUID PRODUCT PHYSICAL ISSUE 56 0.0173
29 PRODUCT OUTER PACKAGING ISSUE 10 0.0173
30 DUPLICATE THERAPY ERROR 3 0.0169
31 DEVICE MALFUNCTION 725 0.0166
32 NAIL PSORIASIS 6 0.0160
33 CYTOLOGY ABNORMAL 2 0.0160
34 SUSPECTED PRODUCT TAMPERING 4 0.0158
35 DEVICE LEAKAGE 299 0.0155
36 PALMOPLANTAR PUSTULOSIS 4 0.0147
37 ERYTHRODERMIC PSORIASIS 9 0.0144
38 DEVICE DEFECTIVE 64 0.0143
39 GENITAL HERPES SIMPLEX 2 0.0138
40 DRUG DELIVERY SYSTEM ISSUE 12 0.0127
41 ICHTHYOSIS 2 0.0123
42 WRONG SCHEDULE 8 0.0115
43 PSORIASIS 1089 0.0114
44 ECZEMA NUMMULAR 3 0.0113
45 ANORECTAL INFECTION 2 0.0112
46 LEUKOPLAKIA 2 0.0110
47 PSORIATIC ARTHROPATHY 262 0.0110
48 PITYRIASIS ROSEA 3 0.0107
49 APPENDICEAL ABSCESS 2 0.0106
50 GUTTATE PSORIASIS 6 0.0106
51 SWEAT GLAND DISORDER 4 0.0102
52 KERATOACANTHOMA 5 0.0102
53 SPINAL DECOMPRESSION 3 0.0100
54 PRODUCT CONTAINER SEAL ISSUE 8 0.0097
55 MANUFACTURING ISSUE 3 0.0097
56 PARAPSORIASIS 2 0.0096
57 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 90 0.0096
58 RECTAL ADENOCARCINOMA 4 0.0093
59 INJECTION RELATED REACTION 8 0.0093
60 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 16 0.0089
61 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0088
62 PRODUCT LABEL ISSUE 41 0.0088
63 PRODUCT DOSE OMISSION 575 0.0086
64 PRODUCT STORAGE ERROR 316 0.0086
65 DEVICE ISSUE 477 0.0086
66 ADMINISTRATION SITE REACTION 2 0.0081
67 CIRRHOSIS ALCOHOLIC 3 0.0081
68 CUTANEOUS T-CELL LYMPHOMA 4 0.0079
69 MANUFACTURING PRODUCT SHIPPING ISSUE 3 0.0078
70 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0076
71 ANTINUCLEAR ANTIBODY INCREASED 6 0.0075
72 PUSTULE 7 0.0075
73 POOR QUALITY PRODUCT ADMINISTERED 34 0.0074
74 PUSTULAR PSORIASIS 18 0.0070
75 ENDOMETRIAL ABLATION 2 0.0070
76 PRODUCT PACKAGING ISSUE 44 0.0068
77 EOSINOPHILIC OESOPHAGITIS 3 0.0062
78 TINEA INFECTION 5 0.0062
79 ECZEMA ASTEATOTIC 2 0.0061
80 UNDERDOSE 330 0.0059
81 FIBROADENOMA OF BREAST 2 0.0056
82 LATENT TUBERCULOSIS 8 0.0055
83 METABOLIC SYNDROME 7 0.0054
84 THERAPEUTIC PRODUCT EFFECT DECREASED 139 0.0053
85 HEPATOSPLENOMEGALY 11 0.0052
86 SKIN PLAQUE 30 0.0051
87 MEGACOLON 6 0.0050
88 BODY TINEA 2 0.0050
89 ANTIBIOTIC THERAPY 3 0.0049
90 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0048
91 ENDOMETRIAL CANCER 8 0.0047
92 OXYGEN THERAPY 4 0.0046
93 BREAST CANCER MALE 2 0.0046
94 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 392 0.0045
95 PRODUCT COMPLAINT 57 0.0044
96 BLOOD CREATININE DECREASED 10 0.0043
97 VARICES OESOPHAGEAL 10 0.0043
98 PHYSICAL PRODUCT LABEL ISSUE 3 0.0042
99 PROSTATE INFECTION 3 0.0041
100 MANTLE CELL LYMPHOMA 4 0.0040
101 COMPLICATION ASSOCIATED WITH DEVICE 40 0.0040
102 LOSS OF THERAPEUTIC RESPONSE 3 0.0039
103 SARS-COV-2 TEST POSITIVE 32 0.0039
104 VACCINATION COMPLICATION 3 0.0039
105 HERPES ZOSTER DISSEMINATED 2 0.0039
106 INGROWN HAIR 2 0.0038
107 CARPAL TUNNEL DECOMPRESSION 3 0.0038
108 GRANULOMA ANNULARE 2 0.0038
109 PRODUCT DISTRIBUTION ISSUE 9 0.0038
110 MALIGNANT MELANOMA IN SITU 4 0.0037
111 GENITAL RASH 4 0.0036
112 SUSPECTED COVID-19 9 0.0035
113 BURNS THIRD DEGREE 3 0.0035
114 DRUG EXPOSURE BEFORE PREGNANCY 3 0.0034
115 OPHTHALMIC HERPES ZOSTER 4 0.0034
116 NON-ALCOHOLIC STEATOHEPATITIS 3 0.0033
117 INTERVERTEBRAL DISC OPERATION 3 0.0033
118 PRODUCT PACKAGING QUANTITY ISSUE 19 0.0033
119 PRODUCT ADMINISTRATION ERROR 37 0.0032
120 SYMPTOM RECURRENCE 7 0.0032
121 VULVOVAGINAL CANDIDIASIS 3 0.0032
122 SELF-MEDICATION 10 0.0032
123 DACTYLITIS 2 0.0032
124 ABSCESS DRAINAGE 2 0.0031
125 DEVICE PHYSICAL PROPERTY ISSUE 9 0.0031
126 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0031
127 METABOLIC SURGERY 2 0.0031
128 PRODUCT DISPENSING ERROR 36 0.0030
129 HEPATITIS A 2 0.0030
130 DERMATITIS PSORIASIFORM 4 0.0030
131 CHOLANGIOCARCINOMA 3 0.0029
132 VITILIGO 4 0.0029
133 THERAPY INTERRUPTED 66 0.0029
134 COVID-19 249 0.0029
135 ALCOHOL WITHDRAWAL SYNDROME 2 0.0029
136 COVID-19 IMMUNISATION 2 0.0029
137 NECK SURGERY 4 0.0029
138 MATERNAL EXPOSURE DURING BREAST FEEDING 5 0.0029
139 SKIN STRIAE 3 0.0029
140 DIVERTICULAR PERFORATION 5 0.0028
141 LICHENOID KERATOSIS 4 0.0028
142 CRANIOCEREBRAL INJURY 6 0.0028
143 INTENSIVE CARE 2 0.0028
144 ADENOCARCINOMA PANCREAS 3 0.0028
145 LOWER RESPIRATORY TRACT INFECTION 85 0.0027
146 INSURANCE ISSUE 13 0.0027
147 INFLAMMATORY MARKER INCREASED 8 0.0026
148 WRONG PRODUCT ADMINISTERED 10 0.0026
149 CORONAVIRUS TEST POSITIVE 2 0.0026
150 RESPIRATORY TRACT INFECTION 47 0.0026
151 SQUAMOUS CELL CARCINOMA 19 0.0026
152 DEVICE USE ISSUE 21 0.0026
153 AXILLARY MASS 2 0.0025
154 EMERGENCY CARE 4 0.0025
155 HERPES VIRUS INFECTION 11 0.0025
156 THERAPY NON-RESPONDER 65 0.0025
157 CUTANEOUS VASCULITIS 4 0.0025
158 ACUTE ABDOMEN 3 0.0024
159 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0024
160 CORONAVIRUS INFECTION 10 0.0024
161 THERAPY CESSATION 86 0.0024
162 FUNGAL SKIN INFECTION 7 0.0024
163 SUBCUTANEOUS ABSCESS 9 0.0024
164 INJECTION SITE OEDEMA 3 0.0024
165 LICHEN PLANUS 4 0.0024
166 HIDRADENITIS 8 0.0023
167 INNER EAR DISORDER 2 0.0023
168 FACIAL BONES FRACTURE 8 0.0023
169 ACARODERMATITIS 2 0.0023
170 SPINAL OPERATION 15 0.0022
171 DEVICE DEPLOYMENT ISSUE 15 0.0022
172 ACUTE LEUKAEMIA 3 0.0022
173 INFECTED CYST 2 0.0022
174 STRESS FRACTURE 10 0.0022
175 TUNNEL VISION 3 0.0022
176 COCCIDIOIDOMYCOSIS 2 0.0022
177 HIP SURGERY 7 0.0021
178 INJECTION SITE HAEMORRHAGE 119 0.0021
179 COVID-19 PNEUMONIA 15 0.0021
180 ONYCHOMADESIS 5 0.0021
181 HORDEOLUM 5 0.0021
182 DEVICE CONNECTION ISSUE 2 0.0020
183 HERPES SIMPLEX 10 0.0020
184 DEVICE MECHANICAL ISSUE 3 0.0020
185 DEVICE OCCLUSION 16 0.0020
186 LIMB MASS 3 0.0020
187 CELLULITIS 79 0.0020
188 BACTERIAL VAGINOSIS 2 0.0020
189 MYELITIS TRANSVERSE 2 0.0019
190 HYPERTONIC BLADDER 4 0.0019
191 SKIN DISORDER 45 0.0019
192 SKIN ATROPHY 8 0.0019
193 RENAL MASS 3 0.0019
194 CONNECTIVE TISSUE DISORDER 2 0.0019
195 HEPATIC CIRRHOSIS 25 0.0018
196 SPINAL FUSION SURGERY 5 0.0018
197 BILIARY TRACT DISORDER 2 0.0018
198 PYODERMA GANGRENOSUM 4 0.0018
199 AXILLARY PAIN 2 0.0018
200 IMPETIGO 2 0.0018
201 PEMPHIGOID 9 0.0018
202 INJECTION SITE VESICLES 7 0.0018
203 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0018
204 THERAPEUTIC RESPONSE DECREASED 78 0.0018
205 SKIN INFECTION 14 0.0018
206 LUNG ADENOCARCINOMA 4 0.0018
207 PRODUCT USE ISSUE 235 0.0018
208 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0018
209 TUBERCULOSIS 17 0.0017
210 BACK INJURY 13 0.0017
211 FEELING OF DESPAIR 6 0.0017
212 PNEUMONIA BACTERIAL 10 0.0017
213 LEG AMPUTATION 6 0.0017
214 ORAL HERPES 23 0.0017
215 RECTAL CANCER 4 0.0017
216 FOLLICULITIS 8 0.0017
217 LIMB OPERATION 5 0.0017
218 PAPILLOMA VIRAL INFECTION 2 0.0016
219 JOINT EFFUSION 9 0.0016
220 SKIN HAEMORRHAGE 14 0.0016
221 CARDIAC ABLATION 2 0.0016
222 ALOPECIA AREATA 2 0.0016
223 DERMAL CYST 3 0.0016
224 COLON CANCER METASTATIC 2 0.0016
225 ANIMAL BITE 3 0.0016
226 SHOULDER OPERATION 4 0.0016
227 LAZINESS 2 0.0016
228 KIDNEY INFECTION 23 0.0016
229 PRODUCT AVAILABILITY ISSUE 13 0.0015
230 INJECTION SITE REACTION 82 0.0015
231 APPENDICECTOMY 4 0.0015
232 PRODUCT COLOUR ISSUE 5 0.0015
233 ARTHRITIS 88 0.0015
234 OTITIS MEDIA 4 0.0015
235 PRODUCT USE COMPLAINT 11 0.0015
236 MACULE 3 0.0015
237 ULCERATIVE KERATITIS 3 0.0015
238 COLOSTOMY 2 0.0015
239 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0014
240 UPPER RESPIRATORY TRACT INFECTION 49 0.0014
241 SKIN FISSURES 15 0.0014
242 CONDITION AGGRAVATED 291 0.0014
243 HEAVY MENSTRUAL BLEEDING 3 0.0014
244 SKIN HYPERTROPHY 3 0.0014
245 CHEMOTHERAPY 3 0.0014
246 THERAPY CHANGE 8 0.0014
247 DEVICE FAILURE 15 0.0014
248 PRODUCT PRESCRIBING ERROR 19 0.0014
249 UTERINE CANCER 10 0.0014
250 SWELLING OF EYELID 4 0.0014
251 EXPOSURE VIA SKIN CONTACT 3 0.0014
252 NASAL SEPTUM DEVIATION 2 0.0014
253 MASTITIS 2 0.0013
254 PNEUMONIA VIRAL 3 0.0013
255 INJECTION SITE RASH 28 0.0013
256 IMMUNE SYSTEM DISORDER 13 0.0013
257 ORAL INFECTION 4 0.0013
258 HIV INFECTION 3 0.0013
259 LOCALISED INFECTION 24 0.0013
260 STREPTOCOCCAL INFECTION 5 0.0013
261 DEVICE RELATED SEPSIS 2 0.0013
262 MULTIPLE ALLERGIES 7 0.0013
263 MECHANICAL VENTILATION 2 0.0013
264 FUNGAL INFECTION 32 0.0013
265 ERYSIPELAS 5 0.0013
266 LIVER FUNCTION TEST INCREASED 17 0.0013
267 APPLICATION SITE HAEMORRHAGE 3 0.0012
268 POSTOPERATIVE WOUND INFECTION 6 0.0012
269 EAR INFECTION 22 0.0012
270 STAPHYLOCOCCAL SEPSIS 5 0.0012
271 ANAPHYLACTOID REACTION 4 0.0012
272 LYMPHOCYTOSIS 2 0.0012
273 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 49 0.0012
274 HYPERSENSITIVITY VASCULITIS 3 0.0012
275 PHARYNGEAL SWELLING 6 0.0012
276 DIVERTICULITIS 25 0.0012
277 MUSCLE STRAIN 8 0.0012
278 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 161 0.0012
279 ARTHRALGIA 352 0.0012
280 ABSCESS 14 0.0012
281 HEPATITIS C 13 0.0012
282 PRODUCT USE IN UNAPPROVED INDICATION 172 0.0012
283 INJURY ASSOCIATED WITH DEVICE 15 0.0012
284 BLEPHARITIS 3 0.0012
285 ILLNESS 40 0.0012
286 CERVICAL DYSPLASIA 2 0.0012
287 JOINT STIFFNESS 23 0.0012
288 EXPOSURE DURING PREGNANCY 52 0.0012
289 COLITIS ISCHAEMIC 6 0.0012
290 PULMONARY TUBERCULOSIS 4 0.0012
291 EOSINOPHIL COUNT INCREASED 7 0.0011
292 ECZEMA 24 0.0011
293 OFF LABEL USE 587 0.0011
294 DRUG INEFFECTIVE 1125 0.0011
295 SUNBURN 7 0.0011
296 INFECTIOUS MONONUCLEOSIS 2 0.0011
297 INJECTION SITE INFLAMMATION 4 0.0011
298 INJECTION SITE SWELLING 60 0.0011
299 INJECTION SITE NODULE 10 0.0011
300 SKIN LESION 22 0.0011
301 MENOPAUSE 2 0.0011
302 BASAL CELL CARCINOMA 13 0.0011
303 DERMATITIS CONTACT 9 0.0011
304 JAW FRACTURE 2 0.0011
305 ANAL ABSCESS 4 0.0011
306 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0011
307 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0011
308 GASTROINTESTINAL TUBE INSERTION 2 0.0011
309 PARESIS 2 0.0011
310 HEPATIC ENZYME INCREASED 52 0.0011
311 PRURITUS 269 0.0011
312 DRUG EFFECT LESS THAN EXPECTED 3 0.0011
313 SKIN TIGHTNESS 4 0.0011
314 APPENDICITIS PERFORATED 2 0.0011
315 APPENDICITIS 7 0.0011
316 MALIGNANT MELANOMA 11 0.0010
317 TONSILLITIS 4 0.0010
318 GALLBLADDER OPERATION 3 0.0010
319 NODULE 10 0.0010
320 DERMATITIS ATOPIC 12 0.0010
321 INJECTION SITE EXTRAVASATION 12 0.0010
322 INCORRECT DOSE ADMINISTERED BY DEVICE 12 0.0010
323 NAIL DISCOLOURATION 3 0.0010
324 HEPATOCELLULAR CARCINOMA 6 0.0010
325 OVERWEIGHT 4 0.0010
326 ENDOTRACHEAL INTUBATION 2 0.0010
327 CARDIAC OPERATION 6 0.0010
328 COLITIS MICROSCOPIC 3 0.0010
329 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0010
330 INJECTION SITE DISCOLOURATION 9 0.0010
331 OBESITY 11 0.0010
332 ABSCESS LIMB 3 0.0010
333 CYST 9 0.0010
334 GOUT 13 0.0010
335 INJECTION SITE BRUISING 54 0.0009
336 SURGERY 36 0.0009
337 HYPOKINESIA 11 0.0009
338 ABNORMAL LOSS OF WEIGHT 5 0.0009
339 COLON CANCER 11 0.0009
340 PNEUMONIA 221 0.0009
341 TOOTH INFECTION 9 0.0009
342 FRUSTRATION TOLERANCE DECREASED 5 0.0009
343 ARTHROPOD BITE 5 0.0009
344 ADVERSE DRUG REACTION 54 0.0009
345 TOXIC SKIN ERUPTION 7 0.0009
346 INFLUENZA LIKE ILLNESS 61 0.0009
347 URINARY TRACT DISORDER 3 0.0009
348 FOOT OPERATION 3 0.0009
349 CLUMSINESS 2 0.0009
350 GASTROENTERITIS 10 0.0009
351 NECROSIS 4 0.0009
352 PRODUCT QUALITY ISSUE 104 0.0009
353 SINUS CONGESTION 9 0.0009
354 IMMOBILE 3 0.0009
355 ARTHRITIS INFECTIVE 3 0.0009
356 SKIN EXFOLIATION 51 0.0009
357 INJECTION SITE PRURITUS 43 0.0009
358 GUILLAIN-BARRE SYNDROME 3 0.0009
359 URTICARIA 104 0.0008
360 FOOD POISONING 3 0.0008
361 APPLICATION SITE EXFOLIATION 3 0.0008
362 NEPHRITIS 2 0.0008
363 NECK INJURY 2 0.0008
364 INFECTION 87 0.0008
365 PELVIC FRACTURE 5 0.0008
366 SCAB 7 0.0008
367 BACTERIAL INFECTION 11 0.0008
368 POLYARTHRITIS 3 0.0008
369 DISSOCIATION 3 0.0008
370 PRODUCT SUPPLY ISSUE 3 0.0008
371 KNEE OPERATION 5 0.0008
372 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0008
373 PHARYNGITIS STREPTOCOCCAL 6 0.0008
374 PRODUCT LABEL CONFUSION 3 0.0008
375 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0008
376 CHOLECYSTECTOMY 7 0.0008
377 ERYTHEMA NODOSUM 2 0.0008
378 GESTATIONAL DIABETES 3 0.0008
379 HEPATITIS B 4 0.0008
380 DECREASED IMMUNE RESPONSIVENESS 5 0.0008
381 LYME DISEASE 2 0.0008
382 HERPES ZOSTER 35 0.0008
383 ECTOPIC PREGNANCY 2 0.0008
384 MYASTHENIA GRAVIS 3 0.0008
385 OVARIAN CANCER 6 0.0008
386 GASTROINTESTINAL MOTILITY DISORDER 3 0.0008
387 SCRATCH 5 0.0008
388 DRUG ERUPTION 10 0.0008
389 CANDIDA INFECTION 9 0.0008
390 TREATMENT NONCOMPLIANCE 29 0.0008
391 EYE INFECTION 6 0.0008
392 NEOPLASM MALIGNANT 38 0.0008
393 THROMBOTIC MICROANGIOPATHY 5 0.0008
394 LARYNGITIS 6 0.0008
395 RASH 240 0.0008
396 NASOPHARYNGITIS 99 0.0008
397 INTESTINAL RESECTION 3 0.0008
398 STENT PLACEMENT 5 0.0008
399 ULCER HAEMORRHAGE 4 0.0008
400 BLOOD PHOSPHORUS DECREASED 2 0.0008
401 INFLUENZA 56 0.0007
402 ADVERSE EVENT 53 0.0007
403 VARICOSE VEIN 3 0.0007
404 INJECTION SITE DISCOMFORT 5 0.0007
405 AUTOIMMUNE THYROIDITIS 2 0.0007
406 WOUND INFECTION 5 0.0007
407 FAECES SOFT 3 0.0007
408 SKIN LACERATION 5 0.0007
409 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0007
410 BRONCHITIS 43 0.0007
411 LIMB INJURY 14 0.0007
412 FEAR OF INJECTION 3 0.0007
413 INJECTION SITE PAIN 150 0.0007
414 ERECTILE DYSFUNCTION 14 0.0007
415 SINUSITIS 55 0.0007
416 TOOTH ABSCESS 6 0.0007
417 INJECTION SITE MASS 19 0.0007
418 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0007
419 B-CELL LYMPHOMA 2 0.0007
420 VASCULITIS 6 0.0007
421 POST PROCEDURAL INFECTION 4 0.0007
422 PRODUCT CONTAINER ISSUE 4 0.0007
423 INJECTION SITE ERYTHEMA 66 0.0007
424 ONYCHOMYCOSIS 2 0.0007
425 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0007
426 INJECTION SITE WARMTH 12 0.0007
427 PANIC REACTION 4 0.0007
428 HANGOVER 2 0.0007
429 BLOOD TRIGLYCERIDES INCREASED 10 0.0007
430 TOE AMPUTATION 3 0.0007
431 ADVERSE REACTION 7 0.0007
432 VIRAL INFECTION 16 0.0007
433 KETOACIDOSIS 4 0.0007
434 GAIT INABILITY 13 0.0007
435 SEASONAL ALLERGY 6 0.0007
436 SKIN WARM 3 0.0007
437 HYPERTHYROIDISM 7 0.0007
438 RASH PRURITIC 26 0.0007
439 PRODUCT PRESCRIBING ISSUE 4 0.0007
440 EPSTEIN-BARR VIRUS INFECTION 3 0.0007
441 SKIN MASS 3 0.0006
442 BURNING SENSATION 36 0.0006
443 FURUNCLE 4 0.0006
444 HERNIA 9 0.0006
445 INABILITY TO AFFORD MEDICATION 3 0.0006
446 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0006
447 BLISTER 26 0.0006
448 OROPHARYNGEAL PAIN 43 0.0006
449 RASH PUSTULAR 4 0.0006
450 PERICARDITIS 6 0.0006
451 OESOPHAGEAL PAIN 2 0.0006
452 CYSTITIS 16 0.0006
453 DEVICE DELIVERY SYSTEM ISSUE 4 0.0006
454 HYPERSENSITIVITY 88 0.0006
455 GASTROINTESTINAL INFECTION 4 0.0006
456 RASH GENERALISED 16 0.0006
457 PYELONEPHRITIS 4 0.0006
458 DEMYELINATION 2 0.0006
459 MELANOCYTIC NAEVUS 2 0.0006
460 CONCOMITANT DISEASE AGGRAVATED 3 0.0006
461 EAR PAIN 9 0.0006
462 SECRETION DISCHARGE 5 0.0006
463 PHARYNGITIS 6 0.0006
464 ONYCHOCLASIS 3 0.0006
465 RESPIRATORY TRACT CONGESTION 7 0.0006
466 INFLAMMATION 21 0.0006
467 NEPHROLITHIASIS 20 0.0006
468 CORONARY ARTERY BYPASS 3 0.0006
469 ESCHERICHIA URINARY TRACT INFECTION 2 0.0006
470 ORGANISING PNEUMONIA 2 0.0006
471 PROCEDURAL COMPLICATION 4 0.0006
472 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0006
473 GRIP STRENGTH DECREASED 3 0.0006
474 RASH MACULAR 15 0.0006
475 LIP DRY 3 0.0006
476 KNEE ARTHROPLASTY 8 0.0006
477 STAPHYLOCOCCAL INFECTION 16 0.0006
478 FACE OEDEMA 8 0.0006
479 PNEUMOTHORAX 7 0.0006
480 GOITRE 2 0.0006
481 POST PROCEDURAL COMPLICATION 9 0.0006
482 BEDRIDDEN 6 0.0006
483 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0006
484 NERVE COMPRESSION 4 0.0006
485 PRODUCT PHYSICAL ISSUE 8 0.0006
486 TYPE 2 DIABETES MELLITUS 15 0.0006
487 ACCIDENT 5 0.0006
488 ACUTE CORONARY SYNDROME 4 0.0006
489 BREAST MASS 3 0.0006
490 SEPTIC SHOCK 18 0.0006
491 PAPILLOEDEMA 2 0.0006
492 NONSPECIFIC REACTION 2 0.0006
493 PAIN OF SKIN 12 0.0006
494 LIGAMENT SPRAIN 4 0.0006
495 NIGHT SWEATS 13 0.0006
496 DIARRHOEA HAEMORRHAGIC 4 0.0006
497 APPLICATION SITE DISCOLOURATION 2 0.0005
498 LIVER DISORDER 18 0.0005
499 ABDOMINAL HERNIA 2 0.0005
500 INJECTION SITE URTICARIA 9 0.0005
501 GASTROENTERITIS VIRAL 7 0.0005
502 COLITIS 14 0.0005
503 HEPATIC ENZYME ABNORMAL 2 0.0005
504 ANAL INCONTINENCE 3 0.0005
505 RASH ERYTHEMATOUS 17 0.0005
506 SINUS DISORDER 8 0.0005
507 INTERSTITIAL LUNG DISEASE 19 0.0005
508 JOINT SWELLING 46 0.0005
509 DISEASE RECURRENCE 14 0.0005
510 PERIPHERAL SWELLING 57 0.0005
511 CONCUSSION 3 0.0005
512 PAROSMIA 3 0.0005
513 NAIL DISORDER 3 0.0005
514 PAIN 249 0.0005
515 DRUG DOSE OMISSION BY DEVICE 6 0.0005
516 GASTROINTESTINAL DISORDER 29 0.0005
517 THERAPEUTIC RESPONSE SHORTENED 6 0.0005
518 INJECTION SITE IRRITATION 5 0.0005
519 URINARY TRACT INFECTION 63 0.0005
520 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0005
521 TOOTHACHE 7 0.0005
522 ABDOMINAL TENDERNESS 2 0.0005
523 TREATMENT FAILURE 28 0.0005
524 FACIAL PARALYSIS 3 0.0005
525 INFLAMMATORY BOWEL DISEASE 4 0.0005
526 PULMONARY THROMBOSIS 4 0.0005
527 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0005
528 LIPASE INCREASED 3 0.0005
529 DERMATITIS 7 0.0005
530 CIRCULATORY COLLAPSE 7 0.0005
531 COLITIS ULCERATIVE 13 0.0005
532 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0005
533 PRODUCTIVE COUGH 16 0.0005
534 HEADACHE 235 0.0005
535 BLOOD URIC ACID INCREASED 2 0.0005
536 HYSTERECTOMY 3 0.0005
537 SWELLING 33 0.0005
538 SKIN DISCOLOURATION 17 0.0005
539 INCORRECT DOSE ADMINISTERED 65 0.0005
540 HYPERKERATOSIS 2 0.0005
541 JOINT RANGE OF MOTION DECREASED 4 0.0005
542 CORONARY ARTERIAL STENT INSERTION 2 0.0005
543 CHOLANGITIS 2 0.0005
544 LIVER FUNCTION TEST ABNORMAL 12 0.0005
545 GINGIVITIS 2 0.0005
546 FOOD ALLERGY 2 0.0005
547 HYDROCEPHALUS 2 0.0005
548 INTESTINAL PERFORATION 4 0.0005
549 SEPSIS 40 0.0005
550 HYPERTRIGLYCERIDAEMIA 2 0.0005
551 PAPULE 2 0.0005
552 MENSTRUAL DISORDER 3 0.0005
553 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0005
554 DEVICE BREAKAGE 9 0.0005
555 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0005
556 MUSCULOSKELETAL DISORDER 7 0.0005
557 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11 0.0005
558 MASS 5 0.0004
559 LUNG INFECTION 7 0.0004
560 LYMPHADENOPATHY 12 0.0004
561 ACUTE MYOCARDIAL INFARCTION 11 0.0004
562 ILL-DEFINED DISORDER 14 0.0004
563 INTENTIONAL SELF-INJURY 7 0.0004
564 OSTEOARTHRITIS 14 0.0004
565 DYSURIA 13 0.0004
566 STRESS 23 0.0004
567 SCAR 6 0.0004
568 GENERALISED OEDEMA 4 0.0004
569 RESPIRATORY DISORDER 10 0.0004
570 INTENTIONAL DOSE OMISSION 4 0.0004
571 SWELLING FACE 22 0.0004
572 APHTHOUS ULCER 2 0.0004
573 SKIN CANCER 7 0.0004
574 METABOLIC DISORDER 2 0.0004
575 WOUND 8 0.0004
576 LUNG NEOPLASM MALIGNANT 15 0.0004
577 RETINAL DETACHMENT 3 0.0004
578 EXTRA DOSE ADMINISTERED 9 0.0004
579 UROSEPSIS 3 0.0004
580 ACNE 27 0.0004
581 MENISCUS INJURY 2 0.0004
582 EYE SWELLING 12 0.0004
583 ARTHROPATHY 18 0.0004
584 DIARRHOEA 200 0.0004
585 MIGRAINE 29 0.0004
586 MYALGIA 56 0.0004
587 HEPATIC STEATOSIS 6 0.0004
588 BODY HEIGHT DECREASED 4 0.0004
589 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0004
590 WHITE BLOOD CELL COUNT INCREASED 13 0.0004
591 CARDIAC PACEMAKER INSERTION 2 0.0004
592 HYPERVENTILATION 2 0.0004
593 INGUINAL HERNIA 2 0.0004
594 PANCREATITIS ACUTE 7 0.0004
595 FLANK PAIN 3 0.0004
596 COELIAC DISEASE 3 0.0004
597 BLOOD TEST ABNORMAL 4 0.0004
598 ERYTHEMA MULTIFORME 3 0.0004
599 ALOPECIA 63 0.0004
600 AUTOIMMUNE HEPATITIS 2 0.0004
601 ORAL MUCOSAL BLISTERING 2 0.0004
602 OSTEOMYELITIS 6 0.0004
603 HOSPITALISATION 40 0.0004
604 EXPIRED PRODUCT ADMINISTERED 10 0.0004
605 PULMONARY CONGESTION 4 0.0004
606 HIP ARTHROPLASTY 4 0.0004
607 PREGNANCY 7 0.0004
608 BRAIN INJURY 3 0.0004
609 TENDON RUPTURE 4 0.0004
610 MENINGITIS 2 0.0004
611 MEDICATION ERROR 17 0.0004
612 LIP SWELLING 10 0.0004
613 ANGIOEDEMA 13 0.0004
614 GASTRITIS 8 0.0004
615 NEPHROTIC SYNDROME 2 0.0004
616 GLOMERULAR FILTRATION RATE DECREASED 3 0.0004
617 THYROID CANCER 4 0.0004
618 SUBARACHNOID HAEMORRHAGE 3 0.0004
619 AUTOIMMUNE DISORDER 2 0.0004
620 SLUGGISHNESS 3 0.0004
621 LOWER LIMB FRACTURE 5 0.0004
622 HUNGER 3 0.0004
623 SKIN REACTION 4 0.0004
624 BREAST CANCER 32 0.0004
625 CARPAL TUNNEL SYNDROME 4 0.0004
626 RENAL PAIN 3 0.0004
627 LARGE INTESTINE POLYP 2 0.0004
628 PRURITUS GENERALISED 8 0.0004
629 SENSORY DISTURBANCE 5 0.0004
630 ABORTION SPONTANEOUS 12 0.0004
631 CHILLS 33 0.0004
632 RHEUMATOID ARTHRITIS 30 0.0004
633 GASTROINTESTINAL CARCINOMA 3 0.0004
634 NEOPLASM 3 0.0004
635 BACTERAEMIA 3 0.0004
636 PAIN IN EXTREMITY 83 0.0004
637 IMMUNOSUPPRESSION 2 0.0004
638 DRUG EFFECT DECREASED 19 0.0004
639 PYREXIA 93 0.0003
640 OESOPHAGITIS 3 0.0003
641 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0003
642 UVEITIS 3 0.0003
643 CONTUSION 25 0.0003
644 IRRITABLE BOWEL SYNDROME 5 0.0003
645 BLOOD CHOLESTEROL INCREASED 12 0.0003
646 SEXUAL DYSFUNCTION 3 0.0003
647 ASTHMA 25 0.0003
648 DRUG DOSE OMISSION 56 0.0003
649 FORMICATION 2 0.0003
650 ANGINA UNSTABLE 2 0.0003
651 NERVE INJURY 3 0.0003
652 BLOOD GLUCOSE FLUCTUATION 3 0.0003
653 COUGH 67 0.0003
654 FOOT FRACTURE 5 0.0003
655 LYMPHOMA 4 0.0003
656 IMMUNODEFICIENCY 3 0.0003
657 DRUG EFFECT INCOMPLETE 12 0.0003
658 CHEST DISCOMFORT 25 0.0003
659 BONE PAIN 15 0.0003
660 DISABILITY 5 0.0003
661 BLOOD URINE PRESENT 5 0.0003
662 MOUTH ULCERATION 5 0.0003
663 CHOLECYSTITIS 3 0.0003
664 FEELING DRUNK 2 0.0003
665 FLUID RETENTION 13 0.0003
666 IMPAIRED DRIVING ABILITY 3 0.0003
667 SMALL INTESTINAL OBSTRUCTION 3 0.0003
668 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
669 HYPERSOMNIA 7 0.0003
670 NASAL CONGESTION 13 0.0003
671 TASTE DISORDER 3 0.0003
672 EPILEPSY 7 0.0003
673 MENTAL IMPAIRMENT 6 0.0003
674 BLOOD POTASSIUM INCREASED 4 0.0003
675 EOSINOPHILIA 4 0.0003
676 ROAD TRAFFIC ACCIDENT 10 0.0003
677 MUSCLE TIGHTNESS 4 0.0003
678 MUSCULOSKELETAL DISCOMFORT 4 0.0003
679 CEREBRAL INFARCTION 6 0.0003
680 MUSCULOSKELETAL STIFFNESS 20 0.0003
681 HEPATITIS 6 0.0003
682 MYOCARDIAL INFARCTION 47 0.0003
683 GINGIVAL BLEEDING 3 0.0003
684 TOOTH EXTRACTION 3 0.0003
685 GASTRIC HAEMORRHAGE 3 0.0003
686 ABDOMINAL DISCOMFORT 37 0.0003
687 LIBIDO DECREASED 3 0.0003
688 INTESTINAL OBSTRUCTION 8 0.0003
689 AMENORRHOEA 4 0.0003
690 EYE PRURITUS 6 0.0003
691 FATIGUE 169 0.0003
692 EXOSTOSIS 2 0.0003
693 LACRIMATION INCREASED 6 0.0003
694 FIBROMYALGIA 5 0.0003
695 HEAD INJURY 7 0.0003
696 BRAIN NEOPLASM 2 0.0003
697 ERYTHEMA 46 0.0003
698 DIABETES MELLITUS 18 0.0003
699 MALAISE 101 0.0003
700 LEUKOCYTOSIS 4 0.0003
701 HIP FRACTURE 7 0.0003
702 HEPATIC FAILURE 7 0.0003
703 DEPRESSION 54 0.0003
704 COLD SWEAT 4 0.0003
705 IRON DEFICIENCY ANAEMIA 2 0.0003
706 ABDOMINAL DISTENSION 22 0.0003
707 CHEST PAIN 42 0.0003
708 FEELING HOT 13 0.0003
709 INJECTION SITE INDURATION 3 0.0003
710 EYE HAEMORRHAGE 3 0.0003
711 PULMONARY MASS 3 0.0003
712 MUSCULOSKELETAL PAIN 13 0.0003
713 CEREBROVASCULAR ACCIDENT 39 0.0003
714 LEUKAEMIA 2 0.0003
715 SWOLLEN TONGUE 7 0.0003
716 FEELING COLD 6 0.0003
717 DRY SKIN 25 0.0003
718 MUSCLE TWITCHING 5 0.0003
719 DISCOMFORT 11 0.0003
720 GASTRIC CANCER 6 0.0003
721 VISUAL IMPAIRMENT 24 0.0003
722 ANKYLOSING SPONDYLITIS 2 0.0003
723 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0003
724 HYPOACUSIS 8 0.0003
725 HYPERTENSION 43 0.0003
726 SKIN BURNING SENSATION 15 0.0003
727 PANCREATITIS 11 0.0003
728 MYELODYSPLASTIC SYNDROME 3 0.0003
729 THYROID DISORDER 3 0.0003
730 BURSITIS 2 0.0003
731 NEPHROPATHY 2 0.0003
732 BACK PAIN 46 0.0003
733 BONE DISORDER 4 0.0003
734 PROSTATE CANCER 19 0.0003
735 INTERVERTEBRAL DISC DEGENERATION 2 0.0003
736 HYPOAESTHESIA ORAL 3 0.0003
737 PROCEDURAL PAIN 5 0.0003
738 BODY TEMPERATURE DECREASED 2 0.0002
739 CONJUNCTIVITIS 3 0.0002
740 FISTULA 2 0.0002
741 SYNOVITIS 3 0.0002
742 JOINT INJURY 4 0.0002
743 ANKLE FRACTURE 3 0.0002
744 ABDOMINAL PAIN UPPER 38 0.0002
745 PANCREATIC CARCINOMA 6 0.0002
746 HOT FLUSH 13 0.0002
747 MUSCLE SPASMS 35 0.0002
748 UPPER LIMB FRACTURE 4 0.0002
749 WEIGHT INCREASED 41 0.0002
750 HEPATOMEGALY 2 0.0002
751 EATING DISORDER 4 0.0002
752 HYPOAESTHESIA 28 0.0002
753 FOOT DEFORMITY 2 0.0002
754 CARDIAC DISORDER 18 0.0002
755 PARAESTHESIA 29 0.0002
756 MULTIPLE SCLEROSIS 9 0.0002
757 MOVEMENT DISORDER 6 0.0002
758 WEIGHT DECREASED 50 0.0002
759 CATARACT 10 0.0002
760 PHOTOSENSITIVITY REACTION 3 0.0002
761 MICTURITION URGENCY 2 0.0002
762 NAUSEA 139 0.0002
763 ABDOMINAL PAIN 41 0.0002
764 DYSPNOEA 99 0.0002
765 UNEVALUABLE EVENT 14 0.0002
766 IMPAIRED WORK ABILITY 4 0.0002
767 BREAST PAIN 2 0.0002
768 HYPERTENSIVE CRISIS 2 0.0002
769 DENTAL CARIES 2 0.0002
770 NERVOUSNESS 10 0.0002
771 HEPATIC FUNCTION ABNORMAL 6 0.0002
772 NEUROPATHY PERIPHERAL 15 0.0002
773 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
774 EPISTAXIS 13 0.0002
775 CHROMATURIA 4 0.0002
776 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
777 BLOOD PRESSURE ABNORMAL 3 0.0002
778 LETHARGY 10 0.0002
779 ILEUS 2 0.0002
780 FALL 55 0.0002
781 THROAT IRRITATION 7 0.0002
782 DEEP VEIN THROMBOSIS 12 0.0002
783 ATRIAL FIBRILLATION 16 0.0002
784 DEVICE DIFFICULT TO USE 5 0.0002
785 ORAL CANDIDIASIS 2 0.0002
786 FLATULENCE 9 0.0002
787 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
788 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
789 IMPAIRED HEALING 5 0.0002
790 HAEMATOCHEZIA 8 0.0002
791 PRESCRIBED OVERDOSE 3 0.0002
792 DEAFNESS 4 0.0002
793 FEELING ABNORMAL 40 0.0002
794 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
795 GALLBLADDER DISORDER 3 0.0002
796 APHONIA 2 0.0002
797 GLAUCOMA 3 0.0002
798 SKIN ULCER 4 0.0002
799 FRACTURE 3 0.0002
800 MYOCARDIAL ISCHAEMIA 2 0.0002
801 PHARYNGEAL OEDEMA 3 0.0002
802 MEMORY IMPAIRMENT 21 0.0002
803 TINNITUS 7 0.0002
804 ANXIETY 45 0.0002
805 HAEMOGLOBIN DECREASED 16 0.0002
806 RHINORRHOEA 9 0.0002
807 LYMPHOPENIA 2 0.0002
808 WHEEZING 8 0.0002
809 RENAL DISORDER 7 0.0002
810 DIZZINESS 74 0.0002
811 SUICIDAL IDEATION 14 0.0002
812 PANCYTOPENIA 8 0.0002
813 FEMUR FRACTURE 5 0.0002
814 THROMBOCYTOPENIA 16 0.0002
815 RIB FRACTURE 3 0.0002
816 PULMONARY EMBOLISM 15 0.0002
817 SYNCOPE 15 0.0002
818 THROMBOSIS 12 0.0002
819 MADAROSIS 2 0.0002
820 PARAESTHESIA ORAL 2 0.0002
821 GASTRIC DISORDER 6 0.0002
822 INJURY 11 0.0002
823 BODY TEMPERATURE INCREASED 3 0.0002
824 ANAPHYLACTIC REACTION 7 0.0002
825 LABORATORY TEST ABNORMAL 4 0.0002
826 HAEMOPTYSIS 4 0.0002
827 BLOOD PRESSURE INCREASED 21 0.0002
828 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0002
829 DYSPEPSIA 13 0.0002
830 CARDIOVASCULAR DISORDER 4 0.0002
831 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0002
832 HYPOTHYROIDISM 4 0.0002
833 PARALYSIS 2 0.0002
834 PERICARDIAL EFFUSION 3 0.0002
835 DEATH 112 0.0002
836 INSOMNIA 37 0.0002
837 PANIC ATTACK 5 0.0002
838 DEVICE USE ERROR 4 0.0002
839 FREQUENT BOWEL MOVEMENTS 3 0.0002
840 DRY EYE 5 0.0002
841 APPLICATION SITE ERYTHEMA 4 0.0002
842 DELUSION 2 0.0002
843 ACUTE MYELOID LEUKAEMIA 2 0.0002
844 MUSCULAR WEAKNESS 15 0.0002
845 DIALYSIS 2 0.0002
846 PULMONARY OEDEMA 6 0.0002
847 NEURALGIA 3 0.0002
848 INTERVERTEBRAL DISC PROTRUSION 3 0.0002
849 FEAR 4 0.0002
850 CORONARY ARTERY OCCLUSION 2 0.0002
851 SEIZURE 13 0.0002
852 ANGINA PECTORIS 4 0.0002
853 NECK PAIN 7 0.0002
854 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0002
855 RENAL IMPAIRMENT 10 0.0002
856 DRUG INTERACTION 20 0.0002
857 BACK DISORDER 2 0.0002
858 HEAD DISCOMFORT 2 0.0002
859 STOMATITIS 7 0.0002
860 AGRANULOCYTOSIS 2 0.0002
861 PALPITATIONS 14 0.0002
862 AGEUSIA 3 0.0002
863 DEMENTIA 3 0.0002
864 DEPRESSED MOOD 6 0.0002
865 NERVOUS SYSTEM DISORDER 4 0.0002
866 OESOPHAGEAL CARCINOMA 4 0.0002
867 PLATELET COUNT DECREASED 12 0.0002
868 DYSPNOEA EXERTIONAL 4 0.0001
869 DECREASED APPETITE 25 0.0001
870 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
871 DRY MOUTH 9 0.0001
872 VOMITING 52 0.0001
873 ACUTE RESPIRATORY FAILURE 2 0.0001
874 LIVER INJURY 2 0.0001
875 ASTHENIA 41 0.0001
876 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
877 NEUTROPHIL COUNT DECREASED 4 0.0001
878 HAEMATURIA 4 0.0001
879 MOOD ALTERED 3 0.0001
880 COGNITIVE DISORDER 5 0.0001
881 IRRITABILITY 7 0.0001
882 HAEMORRHAGE 11 0.0001
883 PLASMA CELL MYELOMA 4 0.0001
884 BLOOD GLUCOSE ABNORMAL 2 0.0001
885 RED BLOOD CELL COUNT DECREASED 3 0.0001
886 HAEMATOMA 3 0.0001
887 ISCHAEMIC STROKE 2 0.0001
888 LUNG DISORDER 5 0.0001
889 OSTEONECROSIS 4 0.0001
890 LOSS OF CONSCIOUSNESS 14 0.0001
891 BLOOD SODIUM DECREASED 2 0.0001
892 ECONOMIC PROBLEM 2 0.0001
893 HYPONATRAEMIA 6 0.0001
894 LACTIC ACIDOSIS 3 0.0001
895 MENTAL STATUS CHANGES 3 0.0001
896 BLINDNESS 4 0.0001
897 AMNESIA 7 0.0001
898 LIMB DISCOMFORT 3 0.0001
899 MENSTRUATION IRREGULAR 3 0.0001
900 NEUTROPENIA 12 0.0001
901 GAIT DISTURBANCE 19 0.0001
902 FEELING JITTERY 2 0.0001
903 HEPATOTOXICITY 2 0.0001
904 POLLAKIURIA 4 0.0001
905 BLOOD GLUCOSE INCREASED 19 0.0001
906 OEDEMA 5 0.0001
907 DRUG HYPERSENSITIVITY 19 0.0001
908 SLEEP DISORDER 6 0.0001
909 SOMNOLENCE 19 0.0001
910 ACUTE KIDNEY INJURY 13 0.0001
911 MENTAL DISORDER 4 0.0001
912 DELIRIUM 3 0.0001
913 HYPERHIDROSIS 12 0.0001
914 CARDIAC FAILURE 7 0.0001
915 ORAL PAIN 2 0.0001
916 TREMOR 15 0.0001
917 MOOD SWINGS 3 0.0001
918 MELAENA 2 0.0001
919 EYE IRRITATION 4 0.0001
920 APPLICATION SITE PAIN 2 0.0001
921 DRUG-INDUCED LIVER INJURY 2 0.0001
922 DRUG RESISTANCE 2 0.0001
923 ANAPHYLACTIC SHOCK 2 0.0001
924 OEDEMA PERIPHERAL 11 0.0001
925 NIGHTMARE 3 0.0001
926 SKIN IRRITATION 4 0.0001
927 HYPOPHAGIA 2 0.0001
928 BLOOD PRESSURE FLUCTUATION 2 0.0001
929 HEART RATE IRREGULAR 2 0.0001
930 OXYGEN SATURATION DECREASED 4 0.0001
931 HYPERGLYCAEMIA 3 0.0001
932 PLEURAL EFFUSION 5 0.0001
933 DIPLOPIA 2 0.0001
934 MENORRHAGIA 2 0.0001
935 DYSPHAGIA 7 0.0001
936 HAEMATEMESIS 2 0.0001
937 RENAL FAILURE 11 0.0001
938 BLOOD CREATININE INCREASED 5 0.0001
939 DEHYDRATION 10 0.0001
940 HEART RATE INCREASED 7 0.0001
941 DISTURBANCE IN ATTENTION 4 0.0001
942 RHABDOMYOLYSIS 3 0.0001
943 DISORIENTATION 3 0.0001
944 CARDIAC ARREST 6 0.0001
945 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
946 PRODUCT SUBSTITUTION ISSUE 4 0.0001
947 DYSSTASIA 2 0.0001
948 ABNORMAL BEHAVIOUR 3 0.0001
949 RESPIRATORY FAILURE 5 0.0001
950 CONSTIPATION 13 0.0001
951 DYSGEUSIA 5 0.0001
952 CARDIAC FAILURE CONGESTIVE 6 0.0001
953 EYE DISORDER 2 0.0001
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
955 COMA 3 0.0001
956 EYE PAIN 3 0.0001
957 BLOOD PRESSURE DECREASED 4 0.0001
958 HYPOTENSION 12 0.0001
959 HYPERKALAEMIA 2 0.0001
960 HALLUCINATION 4 0.0001
961 DRUG INTOLERANCE 5 0.0001
962 HEART RATE DECREASED 2 0.0001
963 SPEECH DISORDER 3 0.0001
964 COMPLETED SUICIDE 5 0.0001
965 CONFUSIONAL STATE 9 0.0001
966 CEREBRAL HAEMORRHAGE 2 0.0001
967 DYSPHONIA 3 0.0001
968 VISION BLURRED 7 0.0001
969 EMOTIONAL DISTRESS 7 0.0001
970 OCULAR HYPERAEMIA 2 0.0001
971 DYSKINESIA 2 0.0001
972 VERTIGO 3 0.0001
973 INTENTIONAL PRODUCT MISUSE 4 0.0001
974 CHRONIC KIDNEY DISEASE 4 0.0001
975 HYPOKALAEMIA 2 0.0001
976 MOBILITY DECREASED 3 0.0001
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
978 NO ADVERSE EVENT 6 0.0001
979 OVERDOSE 9 0.0001
980 ANAEMIA 8 0.0001
981 HYPOGLYCAEMIA 2 0.0001
982 BLOOD GLUCOSE DECREASED 2 0.0001
983 DISEASE PROGRESSION 4 0.0000
984 BRADYCARDIA 2 0.0000
985 FLUSHING 4 0.0000
986 INFUSION RELATED REACTION 2 0.0000
987 TACHYCARDIA 3 0.0000
988 BALANCE DISORDER 3 0.0000
989 COLORECTAL CANCER 2 0.0000
990 BLADDER CANCER 2 0.0000
991 TOXICITY TO VARIOUS AGENTS 4 0.0000
992 AGITATION 2 0.0000
993 DRUG ABUSE 2 0.0000